Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome
Clinical trial NCT02291029 · COMPLETED
Trial details
- NCT number
- NCT02291029
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-22
- Primary completion
- 2018-06-29
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.